Bilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause?

dc.creatorShihab, Hasan M
dc.creatorLutwama, Fred
dc.creatorPiloya, Theresa
dc.creatorCastelnuovo, Barbara
dc.creatorKambugu, Andrew D.
dc.creatorColebunders, Robert
dc.date2011-12-30T17:53:45Z
dc.date2011-12-30T17:53:45Z
dc.date2009-03
dc.date.accessioned2018-09-04T12:32:16Z
dc.date.available2018-09-04T12:32:16Z
dc.descriptionCase report
dc.descriptionA large number of patients are switched to second-line antiretroviral therapy, especially in resource limited settings. Lopinavir/Ritonavir is the main drug used in second-line treatment regimens. We describe a patient attending an HIV treatment centre in Kampala, Uganda, who presented with bilateral non-tender pitting inflammatory edema two weeks after switching to a Lopinavir/Ritonavir-containing second-line treatment regimen. The lack of an alternate explanation led us to suspect that Lopinavir/Ritonavir was potentially responsible for the edema
dc.identifierShihab, H.M., Lutwama, F., Piloya, T., Castelnuovo, B., Kambugu, A.D., Colebunders, R. (2009). Bilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause? Journal of Infection in Developing Countries, 3(5)
dc.identifier2036-6590
dc.identifierhttp://hdl.handle.net/10570/276
dc.identifier.urihttp://hdl.handle.net/10570/276
dc.languageen
dc.publisherOpen Learning on Enteric Pathogens
dc.subjectEdema
dc.subjectLopinavir/Ritonavir
dc.subjectResource-limited settings
dc.subjectHIV/AIDS
dc.subjectUganda
dc.subjectAntiretroviral therapy
dc.titleBilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause?
dc.typeJournal article, peer reviewed
Files